Global Research Trends in Robot-Assisted and 3D Printing Technologies for Total Knee Arthroplasty: An Analysis Based on Bibliometrics and Knowledge Graphs

Why It Matters

The fusion of robotics and additive manufacturing is redefining TKA precision, reducing operative variability, and creating new competitive dynamics for device makers and hospitals.

Key Takeaways

• Research output surged post‑2016, especially robot‑assisted TKA studies
• 3D‑printing now supports planning, guide plates, custom implants
• Hotspots focus on osteotomy precision, alignment restoration, prosthesis positioning
• Intelligent robotic systems and biocompatible prints are emerging frontiers
• Domestic robotic platforms approach imported systems in accuracy

Pulse Analysis

The past decade has witnessed an unprecedented adoption of robot‑assisted platforms in total knee arthroplasty, driven by their ability to enhance bone cuts and implant alignment. Early adopters reported reduced learning curves and improved reproducibility, prompting a cascade of clinical trials that cemented robotics as a standard of care in high‑volume centers. This momentum is reflected in the sharp uptick of peer‑reviewed studies after 2016, underscoring both academic interest and commercial investment in surgical automation.

Concurrently, 3D printing has transitioned from a prototyping curiosity to a clinical workhorse for TKA. Surgeons now leverage patient‑specific imaging to fabricate cutting guides and custom‑fit prosthetic components, shortening operative time and potentially improving functional outcomes. Additive manufacturing also reshapes supply chains, allowing hospitals to produce on‑demand implants and reduce inventory costs. Evidence suggests that personalized implants can better match patient anatomy, decreasing wear rates and extending prosthesis longevity.

Looking ahead, the convergence of intelligent robotics with advanced additive manufacturing promises a new era of precision medicine in orthopedics. Emerging systems integrate real‑time sensor data, AI‑driven decision support, and biocompatible materials that can be printed intra‑operatively. Domestic manufacturers, especially in China, are rapidly closing the performance gap with established Western firms, offering cost‑effective alternatives without sacrificing accuracy. Stakeholders should monitor these developments closely, as they will influence procurement strategies, reimbursement models, and the competitive landscape of orthopedic device markets.